Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.30 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.30 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.30 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9053747 | 0.78 | LDHA (0.32) | LDHASRRLMNAALKBH5SUCNR1 | |
| SCHEMBL1853322 | 0.77 | LMNA (0.35) | LDHASRRLMNAALKBH5SUCNR1 | |
| SCHEMBL31000606 | 0.74 | NAALAD2 (0.32) | LMNAEGLN1 | |
| SCHEMBL2558809 | 0.73 | HMGCR (0.40) | LDHASRRLMNAALKBH5SUCNR1 | |
| SCHEMBL7039700 | 0.71 | ALDH1A1 (0.48) | LDHASRR | |
| SCHEMBL345581 | 0.70 | EGLN1 (0.33) | LDHASRRLMNAALKBH5SUCNR1 | |
| SCHEMBL5827218 | 0.70 | LMNA (0.33) | LDHASRRLMNAALKBH5SUCNR1 | |
| SCHEMBL496333 | 0.70 | EGLN1 (0.37) | LDHASRRLMNAALKBH5SUCNR1 | |
| SCHEMBL66245 | 0.70 | — | — | |
| SCHEMBL7571808 | 0.70 | HMGCR (0.37) | LMNAEGLN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115536594-A | 5-amino-2,3-dihydrothiazine-1,4-dione crystal | 麦翠奥制药公司 | 2022-12-30 | — | — | CN | disclosed |
| CN-109071461-B | Method for preparing 5-amino-2, 3-dihydrophthalazine-1, 4-diketone crystal | 麦翠奥制药公司 | 2022-06-21 | — | — | CN | disclosed |
| CN-109563052-A | 5-amino-2, 3-dihydrothiazine-1, 4-dione crystals | 麦翠奥制药公司 | 2019-04-02 | — | — | CN | disclosed |
| CN-109071461-A | The method for preparing 5- amino -2,3- dihydro thiazine -1,4- diketone crystalline solid | 麦翠奥制药公司 | 2018-12-21 | — | — | CN | disclosed |
| WO-2009040085-A2 | USE OF EXENDIN-4 AND OPTIONALLY SALUSIN-ALPHA AS THERAPEUTIC AGENT(S) | MONDOBIOTECH LABORATORIES AG (LI) | 2009-04-02 | — | — | WO | disclosed |
| EP-1150985-B1 | A REAGENT SYSTEM AND METHOD FOR INCREASING THE LUMINESCENCE OF LANTHANIDE(III) MACROCYCLIC COMPLEXES | LEIF ROBERT C (US) | 2004-06-30 | — | — | EP | disclosed |
| US-6750005-B2 | MIXTURE CONTAINING SURFACTANTS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-06-15 | — | — | US | disclosed |
| US-20020132992-A1 | Reagent system and method for increasing the luminescence of lanthanide(III) macrocyclic complexes | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-09-19 | — | — | US | disclosed |
| EP-1150985-A4 | A REAGENT SYSTEM AND METHOD FOR INCREASING THE LUMINESCENCE OF LANTHANIDE(III) MACROCYCLIC COMPLEXES | LEIF ROBERT C (US) | 2002-03-20 | — | — | EP | disclosed |
| US-6340744-B1 | SPECTROFLUORIMETRICALLY DETECTION MACROCYCLIC COMPLEX | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-01-22 | — | — | US | disclosed |
| EP-1150985-A1 | A REAGENT SYSTEM AND METHOD FOR INCREASING THE LUMINESCENCE OF LANTHANIDE(III) MACROCYCLIC COMPLEXES | Leif, Robert C. (US) | 2001-11-07 | — | — | EP | disclosed |
| WO-2000042048-A1 | A REAGENT SYSTEM AND METHOD FOR INCREASING THE LUMINESCENCE OF LANTHANIDE(III) MACROCYCLIC COMPLEXES | LEIF ROBERT C (US) | 2000-07-20 | — | — | WO | disclosed |